Loss-of-function mutations in BRCA1 and BRCA2 are detected in at least 5% of unselected
patients with breast cancer (BC). These BC susceptibility genes encode proteins critical for …

Despite dramatic advances in cancer research setting, breast cancer remains a major health
problem and represents currently a top biomedical research priority. Worldwide, breast …

Breast cancer is the most common cancer diagnosis in women aged less than 40 years and
the second most common cause of cancer death in this age group. Global rates of young …

Breast cancer is the most frequent cancer in women all over the world. The prognosis is
generally good, with a five-year overall survival rate above 90% for all stages. It is still the …

Breast cancer becomes the second major cause of death among women cancer patients
worldwide. Based on research conducted in 2019, there are approximately 250,000 women …

Background The association between air pollution and green spaces with breast cancer risk
stratified by menopausal status has not been frequently investigated despite its importance …

Abstract Background In the Phase III OlympiAD study, olaparib significantly prolonged
progression-free survival versus chemotherapy treatment of physician's choice (TPC) in …

Background Breast cancer susceptibility gene (BRCA) mutation carriers are at an increased
risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is …

Breast cancer has different epidemio-clinical characteristics in Middle East and North-
African populations compared to those reported in the Western countries. The aim of this …

Abstract Nuclear Power Plants (NPP) are widely utilized around the globe from different
base forms as it is one of the most dependable renewable resources that technological …